TABLE 2.
Twelve-week change (Δ) in selected metabolic parameters1
| Placebo (n = 50) | Ergocalciferol (n = 40) | P value | |
| Δ BMI, kg/m2 | 0.0 ± 0.8 | 0.3 ± 0.6 | 0.08 |
| Δ Waist-to-hip ratio | −0.01 ± 0.03 | 0.01 ± 0.05 | 0.26 |
| Δ Systolic blood pressure, mm Hg | −1 ± 11 | −1 ± 7 | 0.87 |
| Δ Diastolic blood pressure, mm Hg | 0 ± 8 | −1 ± 8 | 0.38 |
| Δ Total cholesterol, mg/dL | 2 ± 25 | 6 ± 21 | 0.38 |
| Δ HDL cholesterol, mg/dL | −3 ± 10 | −1 ± 6 | 0.21 |
| Δ LDL cholesterol, mg/dL | 5 ± 20 | 8 ± 17 | 0.50 |
| Δ Triglycerides, mg/dL | 1 ± 35 | −3 ± 37 | 0.64 |
Values are means ± SDs of baseline values subtracted from week 12 values. P values were calculated by t test.